Subscribe to Science Friday
In March, China became the first country to approve an invasive brain-computer interface beyond clinical trials. The implant, called NEO, is now available to some patients with limb paralysis due to a spinal cord injury. Ira talks with Wired staff writer Emily Mullin about the significance of this milestone.
Plus, brain implants aren’t the only development: China’s entire biotech industry has skyrocketed in recent years. A decade ago, about 8% of new drug molecules were discovered in China. Now it’s over 40%. And more clinical trials are now being conducted there than in the U.S. or Europe. Ira talks with health policy researcher So-Yeon Kang, who’s been following the Chinese pharma industry’s meteoric rise.
Donate To Science Friday
Invest in quality science journalism by making a donation to Science Friday.
Segment Guests
Emily Mullin
Emily Mullin is a staff writer at Wired.
So-Yeon Kang
Dr. So-Yeon Kang is an Assistant Professor of Health Management and Policy at Georgetown University.
Segment Transcript
The transcript is being processed. It will be available 2-3 days after this story’s publication date.
Meet the Producers and Host
About Ira Flatow
Ira Flatow is the founder and host of Science Friday. His green thumb has revived many an office plant at death’s door.
About Shoshannah Buxbaum
Shoshannah Buxbaum is a producer for Science Friday. She’s particularly drawn to stories about health, psychology, and the environment. She’s a proud New Jersey native and will happily share her opinions on why the state is deserving of a little more love.